Literature DB >> 15517451

Application of lower fluence rate for less microvasculature damage and greater cell-killing during photodynamic therapy.

Tao Xu1, Yingxing Li, Xing Wu.   

Abstract

During the process of photodynamic therapy (PDT), problems arise such as stasis or occlusion of microvasculature, tumor oxygen depletion, and photosensitizer bleaching. This study shows that the first problem could be reduced by using a lower fluence rate light source in PDT. Microvasculature damage was studied experimentally in hematoporphyrin derivative-mediated PDT against light fluence rate, and, to some extent, less microvasculature damage was induced under 75 mW/cm(2) illumination than under 150 mW/cm(2). Histology of vessels at the end of PDT showed that vessel damage could be observed in both groups, indicating that the microvasculature would eventually be damaged as long as the administration of light fluence was sufficient and regardless of the illuminating fluence rates. Thus microvasculature damage induced by low fluence rate illumination could also be effective in tumor control after PDT. The cell-killing experiment was performed in vitro and designed so that cell-killing rate was influenced only by light characteristics. The higher cell-killing rate caused by 75 mW/cm(2) illumination indicated that lower fluence rate light could enhance the light absorbency or decrease the bleaching of photosensitizer.

Entities:  

Mesh:

Year:  2004        PMID: 15517451     DOI: 10.1007/s10103-004-0310-1

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  17 in total

1.  Oxygen consumption and diffusion effects in photodynamic therapy.

Authors:  T H Foster; R S Murant; R G Bryant; R S Knox; S L Gibson; R Hilf
Journal:  Radiat Res       Date:  1991-06       Impact factor: 2.841

2.  The importance of fluence rate in photodynamic therapy: is there a parallel with ionizing radiation dose-rate effects?

Authors:  R B Veenhuizen; F A Stewart
Journal:  Radiother Oncol       Date:  1995-11       Impact factor: 6.280

3.  The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy.

Authors:  T M Sitnik; B W Henderson
Journal:  Photochem Photobiol       Date:  1998-04       Impact factor: 3.421

4.  Oxygen monitoring during 5-aminolaevulinic acid induced photodynamic therapy in normal rat colon. Comparison of continuous and fractionated light regimes.

Authors:  A Curnow; J C Haller; S G Bown
Journal:  J Photochem Photobiol B       Date:  2000-11       Impact factor: 6.252

5.  Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect.

Authors:  D J Robinson; H S de Bruijn; N van der Veen; M R Stringer; S B Brown; W M Star
Journal:  Photochem Photobiol       Date:  1998-01       Impact factor: 3.421

6.  Superficial blood flow following photodynamic therapy of malignant non-melanoma skin tumours measured by laser Doppler perfusion imaging.

Authors:  I Wang; S Andersson-Engels; G E Nilsson; K Wårdell; K Svanberg
Journal:  Br J Dermatol       Date:  1997-02       Impact factor: 9.302

7.  Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate.

Authors:  B W Henderson; T M Busch; L A Vaughan; N P Frawley; D Babich; T A Sosa; J D Zollo; A S Dee; M T Cooper; D A Bellnier; W R Greco; A R Oseroff
Journal:  Cancer Res       Date:  2000-02-01       Impact factor: 12.701

8.  In vivo tumor oxygen tension measurements for the evaluation of the efficiency of photodynamic therapy.

Authors:  B J Tromberg; A Orenstein; S Kimel; S J Barker; J Hyatt; J S Nelson; M W Berns
Journal:  Photochem Photobiol       Date:  1990-08       Impact factor: 3.421

9.  Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD).

Authors:  V H Fingar; P K Kik; P S Haydon; P B Cerrito; M Tseng; E Abang; T J Wieman
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

10.  Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate.

Authors:  T M Sitnik; J A Hampton; B W Henderson
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

View more
  1 in total

1.  Mechanisms in photodynamic therapy: Part three-Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction.

Authors:  Ana P Castano; Tatiana N Demidova; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2005-08-10       Impact factor: 3.631

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.